ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Haibo Cheng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5121381375. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper

Papers 1

Targeting CYBA inhibits hepatic metastasis of pancreatic cancer through AKT/MLC2 pathway. Last author DOI 10.1038/s41401-026-01880-z ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiangang Zhao · 1 shared paper, 2026 · strength 0.27
- Paper Targeting CYBA inhibits hepatic metastasis of pancreatic cancer through AKT/MLC2 pathway. DOI 10.1038/s41401-026-01880-z ↗
Hao Chen · 1 shared paper, 2026 · strength 0.27
- Paper Targeting CYBA inhibits hepatic metastasis of pancreatic cancer through AKT/MLC2 pathway. DOI 10.1038/s41401-026-01880-z ↗
Hao-jie Du · 1 shared paper, 2026 · strength 0.27
- Paper Targeting CYBA inhibits hepatic metastasis of pancreatic cancer through AKT/MLC2 pathway. DOI 10.1038/s41401-026-01880-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.